These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34643822)

  • 1. Successful treatment of bepridil-induced intraoperative torsades de pointes by isoproterenol infusion.
    Shimano K; Chang K; Hara Y; Yasuda A; Sawamura S
    JA Clin Rep; 2021 Oct; 7(1):76. PubMed ID: 34643822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
    Makkar RR; Fromm BS; Steinman RT; Meissner MD; Lehmann MH
    JAMA; 1993 Dec; 270(21):2590-7. PubMed ID: 8230644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terminology of torsades de pointes.
    Tzivoni D; Keren A; Banai S; Stern S
    Cardiovasc Drugs Ther; 1991 Apr; 5(2):505-7. PubMed ID: 1854659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsades de pointes associated with acquired long QT syndrome: observation of 7 cases.
    Takahashi N; Ito M; Inoue T; Koumatsu K; Takeshita Y; Tsumabuki S; Tamura M; Inoue K; Maeda T; Saikawa T
    J Cardiol; 1993; 23(1):99-106. PubMed ID: 8164140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental models of torsades de pointes.
    Weissenburger J; Davy JM; Chézalviel F
    Fundam Clin Pharmacol; 1993; 7(1):29-38. PubMed ID: 8458600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglycemia and subsequent torsades de pointes with marked QT prolongation during refeeding.
    Nakashima T; Kubota T; Takasugi N; Kitagawa Y; Yoshida T; Ushikoshi H; Kawasaki M; Nishigaki K; Ogura S; Minatoguchi S
    Nutrition; 2017 Jan; 33():145-148. PubMed ID: 27544004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of cardiac arrest after torsades de pointes due to prolonged QT interval syndrome possibly associated with subarachnoid hemorrhage].
    Yamaguchi S; Watanabe K; Mishio M; Okuda Y; Kitajima T
    Masui; 1999 Jun; 48(6):644-6. PubMed ID: 10402818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bradycardia-Induced Torsades de Pointes in Atrioventricular Block.
    Bhattad PB; Jha A; Wholey R
    Cureus; 2023 Apr; 15(4):e37507. PubMed ID: 37193431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bepridil on cardiac electrophysiologic properties.
    Prystowsky EN
    Am J Cardiol; 1992 Apr; 69(11):63D-67D. PubMed ID: 1553893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of sick sinus syndrome that developed torsades de pointes, pacing failure and sensing failure during administration of bepridil.
    Ohsawa M; Tanaka F; Kunugita F; Saito H; Nakamura M; Shiroto T; Hotta K; Chiba N; Hiramori K
    Jpn Heart J; 2003 Sep; 44(5):783-8. PubMed ID: 14587660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torsades de Pointes.
    Viskin S
    Curr Treat Options Cardiovasc Med; 1999 Aug; 1(2):187-195. PubMed ID: 11096483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug induced QT prolongation].
    Altmann D; Eggmann U; Ammann P
    Wien Klin Wochenschr; 2008; 120(5-6):128-35. PubMed ID: 18365152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of torsades de pointes by atropine.
    Tan HL; Wilde AA; Peters RJ
    Heart; 1998 Jan; 79(1):99-100. PubMed ID: 9505930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization.
    Hasumi H; Matsuda R; Shimamoto K; Hata Y; Kaneko N
    Eur J Pharmacol; 2007 Jan; 555(1):54-60. PubMed ID: 17112502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of bepridil: from review of the European data.
    Coumel P
    Am J Cardiol; 1992 Apr; 69(11):75D-78D. PubMed ID: 1553894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of the additional bepridil treatment in patients with atrial fibrillation refractory to class I antiarrhythmic drugs.
    Miyaji K; Tada H; Fukushima Kusano K; Hashimoto T; Kaseno K; Hiramatsu S; Tadokoro K; Naito S; Nakamura K; Oshima S; Taniguchi K; Ohe T
    Circ J; 2007 Aug; 71(8):1250-7. PubMed ID: 17652890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torsades de Pointes associated with QT prolongation after catheter ablation of paroxysmal atrial fibrillation.
    Park YM; Cha MS; Kang WC; Shin MS; Kim YH; Choi IS; Shin EK
    Indian Pacing Electrophysiol J; 2017; 17(5):146-149. PubMed ID: 29192591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndrome.
    Johansson M; Carlsson L
    J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):247-54. PubMed ID: 11584331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.